Antibody
-
Antibody Drug Conjugate
Antibody Drug Conjugate (ADCs) are monoclonal antibodies attached to biologically active drugs by chemical linkers. These cytotoxic killers are a new frontier in immunotherapy offering tissue targeting capabilities for superior immunological response. Explore the 3D structure of an Antibody Drug Conjugate to learn more about how it combats cancer.
-
Monoclonal IgG4 Antibody bound to PD1
This is a 3D print of a humanized monoclonal IgG4 antibody used in multiple types of cancer treatments. Models available in multiple materials and sizes.
-
MT-3724 Immunotoxin
Protein Description This cytotoxic drug utilizes Molecular Templates an innovative Engineered Toxic Bodies (ETBs) drug delivery platform to trigger cell death. MT-3724 is being developed for the treatment of non-Hodgkin’s Lymphoma and harnesses the immunotherapy power of antibody receptor-specific targeting combined, a bacterial process for cell invasion that infects cancer cells with ribosomal inhibitors that […]